Abstract
Many studies have shown the safety and procedural outcome of the Crosser System in refractory chronic total occlusion (CTO), but no studies have been performed on the use of this device in CTO with percutaneous coronary intervention (PCI) as the primary treatment strategy. We evaluated the advantages of the Crosser Catheter for use in CTO revascularization.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
